Back to Vanguard Group Inc. Vanguard Group Inc.

TVGN

6 quarters

Position history for Vanguard Group Inc.Vanguard Group Inc.'s holdings in TEVOGEN BIO HOLDINGS INC

As of its last 13F, for Q4 2025, Vanguard Group held 1,133,745 shares of TVGN (Tevogen Bio Holdings), worth $375,269. It increased the position by 44,708 shares (+4.1%) from Q3 2025. Vanguard Group held TVGN from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$375,269

Current Shares

1.1M

Total Value Change

+$320,173

Total Shares Change

+984,029

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
1.1M
+4.1%
$375,2690.0%$16.55
17
2025-Q3
Decreased
1.1M
-0.2%
$854,8940.0%$39.25
0
2025-Q2
Increased
1.1M
+4.8%
$1.4M0.0%$62.50
18
2025-Q1
Increased
1M
+617.0%
$1.1M0.0%$54.00
28
2024-Q4
Decreased
145,202
-3.0%
$149,5580.0%$51.50
0
2024-Q3
First report
149,716
-
$55,0960.0%$18.40
0

Other major holders of TVGN: Cantor Fitzgerald, L.P., BlackRock, Inc., Geode Capital Management, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used